Skip to main content
. Author manuscript; available in PMC: 2015 Jan 15.
Published in final edited form as: Cancer Res. 2013 Dec 3;74(2):621–631. doi: 10.1158/0008-5472.CAN-13-1928

Figure 6. Wyeth-14,643 reduces the number of primary and metastatic GFP-A549 cell-derived tumors.

Figure 6

(A) Lungs from athymic mice untreated (a) or treated with Wyeth-14,643 (b–d) isolated 5 weeks after GFP-A549 cell injection. (B) Number of GFP-positive primary (left lung) and metastatic (right lung and liver) tumors detected in freshly isolated organs 5 weeks after tumor cell injection. Values represent the mean +/− S.D. of the organs indicated.